Inspire Medical Systems, Inc. Share Price Target ‘$224.50’, now 14.0% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Inspire Medical Systems, Inc. with ticker code (INSP) now have 16 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $270.00 and $167.00 calculating the average target share price we see $224.50. (at the time of writing). Now with the previous closing price of $197.01 this is indicating there is a potential upside of 14.0%. The day 50 moving average is $159.77 and the 200 moving average now moves to $181.77. The market capitalization for the company is 5.88B. Currently the stock stands at: $197.25 USD

The potential market cap would be $6,703,127,304 based on the market consensus.

The company has a dividend yield of 2.05%. Other points of data to note are a P/E ratio of 896.59, revenue per share of $23.88 and a -1.33% return on assets.

Inspirit Energy Holdings PLC is a United Kingdom-based developer of micro-Combined Heat and Power (microCHP) boilers. The principal activity of the Company is that of an investment company that focuses on investing in disruptive products or technologies that are either proven or at the later stages of development, which own or have exclusive license to the relevant intellectual property. It also applies its expertise in the application of the Stirling engine technology in different sectors, including marine and waste heat recovery. It is also engaged in the development and commercialization of a microCHP boiler for use in commercial and residential markets. The microCHP boiler is powered by natural gas or hydrogen and designed to produce hot water (for domestic hot water or central heating) and a simultaneous electrical output that can be used locally or fed back into the national grid. Its Inspirit Charger can be installed as a standalone, or as the lead appliance in a plant room.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search